Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Haloperidol »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hallucinations < Haloperidol < Halothane  Facettes :

List of bibliographic references indexed by Haloperidol

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
002981 (2005) William G. Honer [Canada] ; Lili C. Kopala ; Jonathan RabinowitzExtrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
002B51 (2005) Tom H. Johnston [Canada] ; Joohyung Lee [Canada] ; Jordi Gomez-Ramirez [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada]A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease
003560 (2000) E. F. Field [Canada] ; I. Q. Whishaw [Canada] ; S. M. Pellis [Canada]Sex differences in catalepsy : evidence for hormone-dependent postural mechanisms in haloperidol-treated rats
003850 (1998) M. Mazurek ; S. Savedia ; R. Bobba ; S. Garside ; P. RosebushPersistent loss of tyrosine hydroxylase immunoreactivity in the substantia nigra after neuroleptic withdrawal
003C96 (1996) J P Doucet [Canada] ; Y. Nakabeppu ; P J Bedard ; B T Hope ; E J Nestler ; B J Jasmin ; J S Chen ; M J Iadarola ; M. St-Jean ; N. Wigle ; P. Blanchet ; R. Grondin ; G S RobertsonChronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
003F10 (1995) P. Seeman [Canada]Therapeutic receptor-blocking concentrations of neuroleptics.
004060 (1995) J. Fang [Canada] ; D. Zuo [Canada] ; P. H. Yu [Canada]Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N -methyl-4-phenylpyridinium (MMP+) towards cultured dopaminergic neuroblastoma cells
004998 (1990) R. T. RossDrug-induced Parkinsonism and other movement disorders
004B44 (1988) G. Chouinard [Canada]The use of benzodiazepines in the treatment of manic-depressive illness.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Haloperidol" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Haloperidol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Haloperidol
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022